Merck KGaA Financially Commits $322 Million Toward Research Center
The complex will research solutions for manufacturing antibodies, mRNA applications, and more.
The Relationship Between Cold Chain Logistics and Cell & Gene Therapies
A one-on-one with Thermo Fisher’s Wilfredo Marin, who dives into the value of ultra-low temperature storage, the need for flexibility in the cold chain logistics space, and more.
Berry Global Increases Manufacturing Capacity
The CDMO’s boost in production will be centered around pharmaceutical products.
Examining Drug Shortages Before and During the COVID-19 Pandemic
There is no doubt that drug shortages are a detriment to the pharma supply chain, but how commonplace were they during the COVID era?
Walgreens Debuts Specialty Pharma Business
The move features the launch of an innovation center revolving around cell and gene services.
Pharma Pulse 4/26/24: Amazon Introduces Custom AI Capabilities, Crafting Culturally Sensitive Messages to Reach Diverse Audience & more
The latest news for pharma industry insiders.
Kühne Holding Inks Deal for Aenova
The company adds a top-10 CDMO to its portfolio in the process, while also expanding its commitment to the pharma industry.
Eli Lilly Purchases Nexus Pharmaceutical Injectables Manufacturing Plant
The deal further grows the Big Pharma company’s US production capabilities, especially when it comes to global parenteral products.
FDA Issues Complete Response Letter to Abeona Therapeutics Regarding PZ-Cel for Recessive Dystrophic Epidermolysis Bullosa
Citing a need for more Chemistry Manufacturing and Controls information, Abeona intends to address the requirements quickly.
Incyte Corporation Inks Deal to Acquire Escient Pharmaceuticals for $750 Million
Deal gives Incyte access to Escient’s pipeline of oral MRGPR antagonists, including EP262 and EP547.
LogiPharma Europe 2024: LogiPharma Commercial Director Discusses Themes of the Show
In an interview with Pharma Commerce Editor Nicholas Saraceno, Will Robinson, Commercial Director, LogiPharma, talks themes of this year's event and future plans for the show.
LogiPharma Europe 2024: Will Robinson Talks Planning LogiPharma
In an interview with Pharma Commerce Editor Nicholas Saraceno, Will Robinson, Commercial Director, LogiPharma, discusses the process of keeping the event relevant to the times.
FDA Approves ImmunityBio’s Anktiva for the Treatment of BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Approval comes amid positive results of a single-arm trial, showing a complete response rate of 77% in patients with Bacillus Calmette-Guérin-unresponsive non-muscle invasive bladder cancer.
Pharma Pulse 4/23/24: Meta Places Smart Assistants Across Its Apps, Burden of Pneumococcal Disease Consistent Across Age Groups & more
Expanse Ice Receives FDA 510(k) Clearance for ICE Aspiration System for Peripheral Arterial, Venous Systems
Technology designed to effectively address blood clots by combining capabilities of larger devices with smaller catheters.
From Toggling Tediously Between Systems to Achieving Whole-Person Care
The rationale behind transforming case management in healthcare.
Pharma Pulse 4/22/24: Will Synthetic, AI-Based Digital Humans Change Pharma and Life Sciences? Climate Change Increases Rate of Infectious Diseases & more
LogiPharma Europe 2024: Niklas Adamsson Discusses Ways to Improve Visibility and Risk Management for Cold Chain Shipping
In an interview with Pharma Commerce Editor Nicholas Saraceno, Niklas Adamsson, COO, Envirotainer, suggests how to improve visibility and risk management for cold chain shipping.
LogiPharma Europe 2024: Envirotainer COO Discusses Reshaping Cold Chain Logistics and Adapting to Disruptions
In an interview with Pharma Commerce Editor Nicholas Saraceno, Niklas Adamsson, COO, Envirotainer, offers his thoughts on how changing customer needs are affecting cold chain logistics.
FDA Approves Takeda’s Subcutaneous Form of Entyvio as a Maintenance Therapy in Adults with Moderately to Severe Crohn Disease
Approval was based on positive data from Takeda’s Phase III VISIBLE 2 study, which displayed long-term clinical remission in approximately half of patients with Crohn disease receiving Entyvio.
Pharma Pulse 4/19/24: The Real Cost of State Drug Importation Programs, Millions in Africa Will Miss HPV Shots After Merck Production Problem & more
LogiPharma Europe 2024: Properly Applying Diversity, Equity, and Inclusion Initiatives Within the Life Sciences Supply Chain
Panel discussion addresses how DE&I can successfully tackle systemic biases and more.
Genentech Shares Promising Results from Phase III OCARINA II Study of Ocrevus for Elapsing, Primary Progressive Multiple Sclerosis
Data displayed rapid and sustained B-cell depletion, with 97.2% of study patients with relapsing and primary progressive multiple sclerosis experiencing no relapses.
LogiPharma Europe 2024: Obstacles Surrounding Personalized Therapy Supply Chains
Session addresses the challenges of implementing autologous/allogeneic cell gene therapies into scalable networks.
Pharma Pulse 4/18/24: Certain Biotech Investors Get an Early Look at Results, An Ethical Outlook for Obesity Drugs & more
LogiPharma Europe 2024: Collaboration on Behalf of Sustainability
A panel uncovers the value in meeting carbon-neutral goals by 2030.
Novartis’ Fabhalta Shows Significant Promise in Reducing Proteinuria in Patients with IgA Nephropathy
Data from the Phase III APPLAUSE-IgAN study showed a 38.3% reduction in proteinuria in patients treated with Fabhalta for IgA nephropathy compared to placebo.
LogiPharma Europe 2024: A Digital Capability Transformation
Panel discussion uncovers how to alter one’s digital know-how for use in temperature-controlled supply chain.
Pharma Pulse 4/17/24: At-Home Patients and AI, Psychedelics Present Unique Ethical Challenges & more
BioHarvest Sciences Expands Operations with New 80,000 Square Foot Facility in Yavne, Israel
Company also purchased equipment for 12 good manufacturing practice clean rooms.
